Edwards Lifesciences (EW) Debt Ratio (2009 - 2026)

Edwards Lifesciences' Debt Ratio history runs 18 years deep, the most recent figure standing at 0.04 for Q1 2026.

• On a quarterly basis, Debt Ratio fell 2.13% year-over-year to 0.04 in Q1 2026; TTM through Mar 2026 was 0.04, a 2.13% decrease from a year earlier, with the FY2025 full-year figure at 0.04, down 4.59% from the prior year.
• Debt Ratio advanced to 0.04 in Q1 2026 per EW's latest filing, from 0.04 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.07 in Q4 2022 and bottomed at 0.04 in Q4 2025.
• The 5-year median for Debt Ratio is 0.06 (2024), against an average of 0.06.
• Across the five-year window, Debt Ratio gained 2.64% in 2022 and fell 28.2% in 2024, its largest moves.
• Year by year, Debt Ratio stood at 0.07 in 2022, then decreased by 11.33% to 0.06 in 2023, then decreased by 28.2% to 0.05 in 2024, then fell by 4.59% to 0.04 in 2025, then climbed by 2.86% to 0.04 in 2026.
• Per Business Quant, the three latest EW Debt Ratio figures stand at 0.04 (Q1 2026), 0.04 (Q4 2025), and 0.05 (Q3 2025).